|
Q1 2021
Filed on May 17, 2021
|
782,670
|
$13.75 - $23.86
$10.8M - $18.7M
|
|
|
Q1 2021
Filed on May 17, 2021
|
200,000,000
|
N/A
|
|
Oxford Immunotec Global PLC
|
Q1 2021
Filed on May 17, 2021
|
1,049,035
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
288,876
|
$45.96 - $68.02
$13.3M - $19.6M
|
|
|
Q1 2021
Filed on May 17, 2021
|
350,000
|
$29.34 - $60.2
$10.3M - $21.1M
|
|
|
Q1 2021
Filed on May 17, 2021
|
565,000
|
$53.26 - $68.08
$30.1M - $38.5M
|
|
|
Q1 2021
Filed on May 17, 2021
|
550,000
|
$27.92 - $52.5
$15.4M - $28.9M
|
|
Longview Acquisition Corp
|
Q1 2021
Filed on May 17, 2021
|
733,333
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
538,721
|
$39.71 - $90.58
$21.4M - $48.8M
|
|
|
Q1 2021
Filed on May 17, 2021
|
125,000
|
$42.5 - $75.37
$5.31M - $9.42M
|
|
|
Q1 2021
Filed on May 17, 2021
|
320,993
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
750,000
|
$16.85 - $23.64
$12.6M - $17.7M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
34,000,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,970,687
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
13,274,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
762,000
|
$23.97 - $61.3
$18.3M - $46.7M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
208,333
|
$66.66 - $111.74
$13.9M - $23.3M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
704,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,150,000
|
$11.06 - $14.01
$12.7M - $16.1M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
700,000
|
$10.05 - $15.01
$7.04M - $10.5M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
68,413
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
450,000
|
$16.48 - $34.3
$7.42M - $15.4M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
175,806
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,200,000
|
$19.0 - $32.63
$22.8M - $39.2M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
2,304,900
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
333,411
|
$66.28 - $93.3
$22.1M - $31.1M
|
|
Arya Sciences Acquistion CO
|
Q4 2020
Filed on Feb 16, 2021
|
500,000
|
N/A
|
|
Longview Acquisition Corp
|
Q4 2020
Filed on Feb 16, 2021
|
2,200,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
300,000
|
$27.04 - $62.21
$8.11M - $18.7M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
825,000
|
$6.51 - $9.33
$5.37M - $7.7M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
5,154,155
|
$1.58 - $4.77
$8.14M - $24.6M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
318,034
|
$19.3 - $26.92
$6.14M - $8.56M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
950,000
|
N/A
|
|
Intercept Pharmaceuticals In
|
Q3 2020
Filed on Nov 16, 2020
|
3,500,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
144,832,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
278,359
|
$19.43 - $35.36
$5.41M - $9.84M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
20,000,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
357,101
|
$4.16 - $6.26
$1.49M - $2.24M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
650,000
|
$27.86 - $39.35
$18.1M - $25.6M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
376,000
|
$141.4 - $257.09
$53.2M - $96.7M
|
|
Millendo Therapeutics Inc
|
Q2 2020
Filed on Aug 14, 2020
|
168,871
|
N/A
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
214,789
|
$8.8 - $12.81
$1.89M - $2.75M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
945,718
|
$14.65 - $24.9
$13.9M - $23.5M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
937,983
|
$7.35 - $10.81
$6.89M - $10.1M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
418,613
|
N/A
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
670,367
|
$14.59 - $36.07
$9.78M - $24.2M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
412,867
|
$60.05 - $98.92
$24.8M - $40.8M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
4,037,305
|
$12.07 - $19.34
$48.7M - $78.1M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
155,380
|
N/A
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
380,300
|
$1.59 - $2.51
$605K - $955K
|
|